Pharmacists' chemo pay row heats up
Failure to resolve the current stoush over the cost of dispensing chemotherapy drugs could force some cancer patients to travel hundreds of kilometres to city hospitals to obtain their medications.
The warning come days after the Federal Government slashed by 70% the subsidies it pays pharmacists to cover the cost of Docetaxel — a drug used to treat breast, prostate and lung cancer.
The move will save around $40 million a year. But pharmacists in private hospitals and community clinics claim they are